These results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the thought of targeting ACKR3 as a singular method to modulate the opioid system, which could open new therapeutic avenues for opioid-linked Issues. Conolidine promises to be a innovative https://nathanielw950jid2.idblogz.com/profile